azathioprine has been researched along with Polymyositis in 51 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Polymyositis: Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The treatment of polymyositis is based on corticosteroid therapy, with addition of azathioprine for non responsive cases or as an attempt to diminish corticosteroids requirements." | 7.81 | What are the effects of adding azathioprine to corticosteroids in polymyositis? ( Meneses, C; Rada, G, 2015) |
| "A 52-year-old man developed therapy-related acute myeloid leukemia (AML) following prolonged immunosuppression with azathioprine for polymyositis." | 7.69 | Therapy-related acute myeloid leukaemia following immunosuppression with azathioprine for polymyositis. ( Adams, P; Dabich, L; Krishnan, K; Sheldon, S; Silveira, S, 1994) |
| "We report one case of dermatomyositis and one case of polymyositis and scleroderma in which the patients' condition improved after treatment with cyclosporine (cyclosporine A)." | 7.68 | Cyclosporine treatment for dermatomyositis/polymyositis. ( Mehregan, DR; Su, WP, 1993) |
| "Leflunomide is a new immunosuppressive drug recently introduced in the treatment of rheumatoid and psoriatic arthritis." | 5.33 | Anti-Jo-1 antibody positive polymyositis--successful therapy with leflunomide. ( Lange, U; Müller-Ladner, U; Piegsa, M; Strunk, J, 2006) |
| " Cyclosporine or tacrolimus have shown efficacy in myositis including those patients with interstitial lung disease (ILD), whereas mycophenolate mofetil is effective in both polymyositis and refractory dermatomyosits (including recalcitrant rash) and ILD." | 4.88 | Therapeutic advances in myositis. ( Aggarwal, R; Oddis, CV, 2012) |
| "The treatment of polymyositis is based on corticosteroid therapy, with addition of azathioprine for non responsive cases or as an attempt to diminish corticosteroids requirements." | 3.81 | What are the effects of adding azathioprine to corticosteroids in polymyositis? ( Meneses, C; Rada, G, 2015) |
| "We identified all patients treated for PM/DM-ILD and assessed cyclophosphamide (CYC), azathioprine (AZA) and mycophenolate (MMF) when used as first-line steroid sparing therapy for effects on pulmonary function variables, dyspnea and tolerance at six and twelve months." | 3.79 | A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis/dermatomyositis. ( Arrossi, V; Chapman, JT; Culver, DA; Mira-Avendano, IC; Parambil, JG; Xu, M; Yadav, R, 2013) |
| " A 67-year-old woman with polymyositis developed mild abdominal pain and abdominal distension during treatment with steroid and azathioprine." | 3.77 | [A case of pneumatosis cystoids intestinalis with polymyositis]. ( Choi, MH; Jang, HJ; Kae, SH; Koh, DH; Kwon, SA; Lee, J; Lee, SJ; Park, JY, 2011) |
| " In univariate analysis, older age at PM/DM onset, anemia, thrombocytopenia, leukopenia, diabetes mellitus, ILD, cancer, and non-use of azathioprine were associated with higher mortality (p = 0." | 3.77 | Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases. ( Chang, HC; Chen, IJ; Ho, HH; Kuo, CF; Luo, SF; See, LC; Shen, YM; Wu, YJ; Yu, KH, 2011) |
| " Three patients with long-standing polymyositis (PM) or dermatomyositis (DM) poorly responsive to prednisone combined with several immunosuppressants were given intravenous rituximab 1,000 mg on Days 0 and 14." | 3.73 | Rituximab as therapy for refractory polymyositis and dermatomyositis. ( Hausner-Sypek, DL; Noss, EH; Weinblatt, ME, 2006) |
| "A 52-year-old man developed therapy-related acute myeloid leukemia (AML) following prolonged immunosuppression with azathioprine for polymyositis." | 3.69 | Therapy-related acute myeloid leukaemia following immunosuppression with azathioprine for polymyositis. ( Adams, P; Dabich, L; Krishnan, K; Sheldon, S; Silveira, S, 1994) |
| " Patients with polyarteritis nodosa (two) or polymyositis (one) were treated with prednisone, which improved their wasting syndrome." | 3.69 | Skeletal muscle studies in patients with HIV-related wasting syndrome. ( Casademont, J; Cebrián, M; Grau, JM; Mallolas, J; Masanés, F; Miró, O; Pedrol, E, 1997) |
| "We report one case of dermatomyositis and one case of polymyositis and scleroderma in which the patients' condition improved after treatment with cyclosporine (cyclosporine A)." | 3.68 | Cyclosporine treatment for dermatomyositis/polymyositis. ( Mehregan, DR; Su, WP, 1993) |
| "Dermatomyositis and polymyositis are rare chronic inflammatory disorders with significant associated morbidity and mortality despite treatment." | 2.52 | The evidence for immunotherapy in dermatomyositis and polymyositis: a systematic review. ( McHugh, NJ; Tansley, SL; Vermaak, E, 2015) |
| "Azathioprine (AZA) is an immunosuppressant commonly used for organ transplantation and autoimmune diseases." | 2.42 | Drug eruption caused by azathioprine: value of using the drug-induced lymphocytes stimulation test for diagnosis. ( Hakamada, A; Isoda, K; Kaketa, M; Mizutani, H; Mori, H; Tamada, K; Yamanaka, K; Yamanishi, K, 2004) |
| "Dermatomyositis is an idiopathic inflammatory myopathy with characteristic skin manifestations." | 2.41 | Dermatomyositis. ( Koler, RA; Montemarano, A, 2001) |
| "Polymyositis is an immune-mediated inflammatory myopathy usually presenting with weakness of proximal muscles in a symmetric pattern." | 1.72 | Generalised oedema as a presenting manifestation of inflammatory myopathy. ( Chandra, A; Ghosh, SK; Karmakar, P; Karmakar, PS; Ray, AK, 2022) |
| "Polymyositis is an inflammatory myopathy which, like SCD, may present with myalgia but is usually associated with proximal muscle weakness." | 1.42 | Juvenile polymyositis with unremitting pain and progressive loss of motor and bulbar function on a background of sickle cell disease. ( Bali, S; D'Cruz, D; Inusa, BP; Lazaro, M, 2015) |
| "Mixed connective tissue disorder (MCTD) with predominant polymyositis and neuropsychiatric manifestations was diagnosed as the patient had anti-RNP positive with significantly raised muscle enzymes." | 1.40 | Depression and seizures as the main neuropsychiatric manifestation of mixed connective tissue disorder. ( Kiani, IG; Qureshi, SH; Shah, F, 2014) |
| "Treating Crohn's disease may lead to improvement in steroid-resistant myositis where the two are associated." | 1.35 | Association of idiopathic inflammatory myopathy and Crohn's disease. ( Danko, K; Dezso, B; Gunasekera, W; Kulcsar, I; Lukacs, S; Nagy-Toldi, A; Szabo, N, 2009) |
| "Leflunomide is a new immunosuppressive drug recently introduced in the treatment of rheumatoid and psoriatic arthritis." | 1.33 | Anti-Jo-1 antibody positive polymyositis--successful therapy with leflunomide. ( Lange, U; Müller-Ladner, U; Piegsa, M; Strunk, J, 2006) |
| "Pharyngeal dysphagia can be the only clinical manifestation of polymyositis, usually a systemic disease." | 1.29 | [Pharyngeal dysphagia and polymyositis]. ( Bernades, P; Chemtob, A; Lévy, H; Lévy, P; Malka, D; Ponsot, P, 1993) |
| "Although most patients with inclusion body myositis have characteristic muscle biopsy findings, some cannot be distinguished histologically early from polymyositis." | 1.29 | Inclusion body myositis: clinical and pathological boundaries. ( Amato, AA; Barohn, RJ; Bryan, WW; Gronseth, GS; Jackson, CE; Katz, JS; Wolfe, GI, 1996) |
| "Both alopecia and polymyositis are rarely associated with inflammatory bowel disease; thus, they have to be discussed as extraintestinal manifestations." | 1.29 | Polymyositis, alopecia universalis, and primary sclerosing cholangitis in a patient with Crohn's disease. ( Jakob, F; Klein, R; Seibold, F, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 15 (29.41) | 18.2507 |
| 2000's | 15 (29.41) | 29.6817 |
| 2010's | 20 (39.22) | 24.3611 |
| 2020's | 1 (1.96) | 2.80 |
| Authors | Studies |
|---|---|
| Ray, AK | 1 |
| Karmakar, P | 1 |
| Chandra, A | 1 |
| Ghosh, SK | 1 |
| Karmakar, PS | 1 |
| Hartung, DM | 1 |
| Johnston, K | 1 |
| Cohen, DM | 1 |
| Nguyen, T | 1 |
| Deodhar, AA | 1 |
| Bourdette, DN | 1 |
| Keyßer, G | 1 |
| Zierz, S | 1 |
| Kornhuber, M | 1 |
| Mira-Avendano, IC | 1 |
| Parambil, JG | 1 |
| Yadav, R | 1 |
| Arrossi, V | 1 |
| Xu, M | 1 |
| Chapman, JT | 1 |
| Culver, DA | 1 |
| Adelowo, OO | 1 |
| Edomwonyi, U | 1 |
| Olaosebikan, H | 1 |
| Kiani, IG | 1 |
| Qureshi, SH | 1 |
| Shah, F | 1 |
| Bali, S | 1 |
| D'Cruz, D | 1 |
| Lazaro, M | 1 |
| Inusa, BP | 1 |
| Meneses, C | 1 |
| Rada, G | 1 |
| Vermaak, E | 1 |
| Tansley, SL | 1 |
| McHugh, NJ | 1 |
| Robles-Perez, A | 1 |
| Molina-Molina, M | 1 |
| Muñoz Gómez, MM | 1 |
| Montané, E | 1 |
| Arellano, AL | 1 |
| Olivé, A | 1 |
| Murase, C | 1 |
| Ogawa, Y | 1 |
| Yamamoto, A | 1 |
| Iriyama, C | 1 |
| Akiyama, M | 1 |
| Takahashi, T | 1 |
| Nakanishi, T | 1 |
| Hamaguchi, Y | 1 |
| Tanaka, T | 1 |
| Fujimoto, N | 1 |
| Polosa, R | 1 |
| Di Mauro, C | 1 |
| Spampinato, B | 1 |
| Castelli, L | 1 |
| D'Amico, G | 1 |
| Edwards, CJ | 1 |
| Russo, C | 1 |
| Szabo, N | 1 |
| Lukacs, S | 1 |
| Kulcsar, I | 1 |
| Gunasekera, W | 1 |
| Nagy-Toldi, A | 1 |
| Dezso, B | 1 |
| Danko, K | 2 |
| Chakour, R | 1 |
| Leimgruber, A | 1 |
| Bart, PA | 2 |
| Spertini, F | 1 |
| Choy, EH | 2 |
| Hoogendijk, JE | 2 |
| Lecky, B | 2 |
| Winer, JB | 2 |
| Gordon, P | 1 |
| Nakamura, H | 1 |
| Fujikawa, K | 1 |
| Kawakami, A | 1 |
| Tamai, M | 1 |
| Yamasaki, S | 1 |
| Ida, H | 1 |
| Eguchi, K | 1 |
| Lee, SJ | 1 |
| Park, JY | 1 |
| Kwon, SA | 1 |
| Koh, DH | 1 |
| Choi, MH | 1 |
| Jang, HJ | 1 |
| Kae, SH | 1 |
| Lee, J | 1 |
| Oliveira, A | 1 |
| Sanches, M | 1 |
| Selores, M | 1 |
| Yu, KH | 1 |
| Wu, YJ | 1 |
| Kuo, CF | 1 |
| See, LC | 1 |
| Shen, YM | 1 |
| Chang, HC | 1 |
| Luo, SF | 1 |
| Ho, HH | 1 |
| Chen, IJ | 1 |
| Vincze, M | 1 |
| Schiopu, E | 1 |
| Phillips, K | 1 |
| MacDonald, PM | 1 |
| Crofford, LJ | 1 |
| Somers, EC | 1 |
| Luca, NJ | 1 |
| Atkinson, A | 1 |
| Hawkins, C | 1 |
| Feldman, BM | 1 |
| Aggarwal, R | 1 |
| Oddis, CV | 1 |
| Ryan, A | 1 |
| Nor, AM | 1 |
| Costigan, D | 1 |
| Foley-Nolan, D | 1 |
| El-Rafie, A | 1 |
| Farrell, MA | 1 |
| Hardiman, O | 1 |
| Gainon, J | 1 |
| Waeber, G | 1 |
| Mori, H | 1 |
| Yamanaka, K | 1 |
| Kaketa, M | 1 |
| Tamada, K | 1 |
| Hakamada, A | 1 |
| Isoda, K | 1 |
| Yamanishi, K | 1 |
| Mizutani, H | 1 |
| Golding, RM | 1 |
| Giles, LG | 1 |
| Noss, EH | 1 |
| Hausner-Sypek, DL | 1 |
| Weinblatt, ME | 1 |
| Lange, U | 1 |
| Piegsa, M | 1 |
| Müller-Ladner, U | 1 |
| Strunk, J | 1 |
| Shirai, Y | 1 |
| Koizumi, K | 1 |
| Ogawa, R | 1 |
| Suzuki, T | 1 |
| Koido, N | 1 |
| Ohosone, Y | 1 |
| Akizuki, S | 1 |
| Takada, T | 1 |
| Hirakata, M | 1 |
| Ishihara, T | 1 |
| Fischer, A | 1 |
| Krishnan, K | 1 |
| Adams, P | 1 |
| Silveira, S | 1 |
| Sheldon, S | 1 |
| Dabich, L | 1 |
| Chemtob, A | 1 |
| Malka, D | 1 |
| Lévy, P | 1 |
| Lévy, H | 1 |
| Ponsot, P | 1 |
| Bernades, P | 1 |
| Pincus, T | 1 |
| Hsue, YT | 1 |
| Paulus, HE | 1 |
| Coulson, WF | 1 |
| Mehregan, DR | 1 |
| Su, WP | 1 |
| Joffe, MM | 1 |
| Greenland, S | 1 |
| Amato, AA | 1 |
| Gronseth, GS | 1 |
| Jackson, CE | 1 |
| Wolfe, GI | 1 |
| Katz, JS | 1 |
| Bryan, WW | 1 |
| Barohn, RJ | 1 |
| Seibold, F | 1 |
| Klein, R | 1 |
| Jakob, F | 1 |
| Villalba, L | 1 |
| Adams, EM | 1 |
| Mader, R | 1 |
| Miró, O | 1 |
| Pedrol, E | 1 |
| Cebrián, M | 1 |
| Masanés, F | 1 |
| Casademont, J | 1 |
| Mallolas, J | 1 |
| Grau, JM | 1 |
| van Vonderen, MG | 1 |
| ter Maaten, JC | 1 |
| van der Valk, P | 1 |
| Hoorntje, SJ | 1 |
| Gans, RO | 1 |
| Yoshida, T | 1 |
| Koga, H | 1 |
| Saitoh, F | 1 |
| Sakamoto, M | 1 |
| Harada, M | 1 |
| Yoshida, H | 1 |
| Sakisaka, S | 1 |
| Sata, M | 1 |
| de Kruijf, EJ | 1 |
| Rothbarth, J | 1 |
| van Duinen, SG | 1 |
| de Meijer, PH | 1 |
| Meinders, AE | 1 |
| Mimura, T | 1 |
| Kanda, H | 1 |
| Kubo, K | 1 |
| Koler, RA | 1 |
| Montemarano, A | 1 |
| Stoll, T | 1 |
| Michel, BA | 1 |
| Neidhart, M | 1 |
| Wassmer, P | 1 |
| Neidl, K | 1 |
| Fehr, K | 1 |
| Wagenhäuser, FJ | 1 |
14 reviews available for azathioprine and Polymyositis
| Article | Year |
|---|---|
Inflammatory myopathies in Nigerians: case series and literature review.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Dermatomyositis; Electromyography; Female; Humans; Imm | 2013 |
The evidence for immunotherapy in dermatomyositis and polymyositis: a systematic review.
Topics: Adrenal Cortex Hormones; Azathioprine; Biological Products; Cyclosporine; Dermatomyositis; Evidence- | 2015 |
Treatment Considerations of Lung Involvement in Rheumatologic Disease.
Topics: Adrenal Cortex Hormones; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cyclophosphamide | 2015 |
WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
Topics: Azathioprine; Blood Component Removal; Cyclosporine; Dermatomyositis; Humans; Immunosuppressive Agen | 2009 |
[New therapeutic approaches for polymyositis and dermatomyositis].
Topics: Adrenal Cortex Hormones; Algorithms; Antineoplastic Agents; Azathioprine; Biological Therapy; Cell M | 2011 |
Therapeutic advances in myositis.
Topics: Azathioprine; Cyclosporine; Dermatomyositis; Drug Resistance; Drug Therapy, Combination; Glucocortic | 2012 |
Drug eruption caused by azathioprine: value of using the drug-induced lymphocytes stimulation test for diagnosis.
Topics: Azathioprine; Diagnosis, Differential; Drug Eruptions; Female; Humans; Immunosuppressive Agents; Lym | 2004 |
Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
Topics: Azathioprine; Blood Component Removal; Cyclosporine; Dermatomyositis; Humans; Immunosuppressive Agen | 2005 |
Update on therapy for refractory dermatomyositis and polymyositis.
Topics: Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Dermatomyositis; Drug Therapy, Combinati | 1996 |
[Treating polymyositis: methotrexate or azathioprine?].
Topics: Azathioprine; Humans; Methotrexate; Polymyositis | 1997 |
[Patient with eosinophilic polymyositis].
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Diagnosis, Differential; Drug Therapy, Combination; E | 2000 |
[Treatment of steroid-resistant polymyositis and dermatomyositis].
Topics: Animals; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Dermatomyositis; Dr | 2001 |
Dermatomyositis.
Topics: Adult; Azathioprine; Child; Dermatologic Agents; Dermatomyositis; Diagnosis, Differential; Female; H | 2001 |
[Polymyositis: disease course and therapy with intravenously administered immunoglobulins].
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Clinical Enzyme Tests; Cyclophosphamide; Dermatomyosit | 1992 |
1 trial available for azathioprine and Polymyositis
| Article | Year |
|---|---|
Standardized estimates from categorical regression models.
Topics: Algorithms; Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Confidence Intervals; Confoundin | 1995 |
36 other studies available for azathioprine and Polymyositis
| Article | Year |
|---|---|
Generalised oedema as a presenting manifestation of inflammatory myopathy.
Topics: Azathioprine; Edema; Female; Humans; Muscle Weakness; Myositis; Polymyositis | 2022 |
Elephant in the room.
Topics: Adrenocorticotropic Hormone; Azathioprine; Dermatomyositis; Humans; Polymyositis | 2019 |
Treatment of adult idiopathic inflammatory myopathies with conventional immunosuppressive drugs : Results of a retrospective study.
Topics: Adult; Azathioprine; Connective Tissue Diseases; Dermatomyositis; Drug Therapy, Combination; Female; | 2019 |
A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis/dermatomyositis.
Topics: Adult; Azathioprine; Cyclophosphamide; Dermatomyositis; Drug Administration Schedule; Drug Resistanc | 2013 |
Depression and seizures as the main neuropsychiatric manifestation of mixed connective tissue disorder.
Topics: Adult; Antibodies, Antinuclear; Anticonvulsants; Antidepressive Agents, Second-Generation; Azathiopr | 2014 |
Juvenile polymyositis with unremitting pain and progressive loss of motor and bulbar function on a background of sickle cell disease.
Topics: Adolescent; Adrenal Cortex Hormones; Anemia, Sickle Cell; Anti-Inflammatory Agents; Autoimmunity; Az | 2015 |
What are the effects of adding azathioprine to corticosteroids in polymyositis?
Topics: Azathioprine; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; Polymyos | 2015 |
[Tacrolimus-induced gynecomastia in a patient with polymyositis].
Topics: Azathioprine; Drug Substitution; Drug Therapy, Combination; Gynecomastia; Humans; Immunosuppressive | 2016 |
Epstein-Barr Virus-associated Natural Killer/T-cell Lymphoma in a Patient Receiving Therapy with Anti-Tumour Necrosis Factor and Thiopurine.
Topics: Adalimumab; Adult; Anti-Inflammatory Agents; Azathioprine; Drug Therapy, Combination; Epstein-Barr V | 2017 |
Case of anti-RuvBL1/2 antibody-positive morphea and polymyositis.
Topics: Adult; ATPases Associated with Diverse Cellular Activities; Autoantibodies; Azathioprine; Carrier Pr | 2017 |
A patient with antihistidyl-tRNA synthetase positive polymyositis presenting as acute respiratory distress syndrome.
Topics: Antirheumatic Agents; Autoantibodies; Azathioprine; Female; Histidine-tRNA Ligase; Humans; Lung Dise | 2008 |
Association of idiopathic inflammatory myopathy and Crohn's disease.
Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease | 2009 |
[Therapeutic strategies in idiopatic inflammatory myopathies].
Topics: Adolescent; Age Factors; Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Biopsy; Dermatomyos | 2009 |
Long-term efficacy of intravenously administered immunoglobulin in a case of polymyositis with limited application of steroid therapy.
Topics: Aged; Azathioprine; Creatine Kinase; Cyclosporine; Humans; Immunoglobulins, Intravenous; Immunosuppr | 2010 |
[A case of pneumatosis cystoids intestinalis with polymyositis].
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azathioprine; Cefotaxime; Female; Humans; Oxy | 2011 |
Azathioprine-induced pellagra.
Topics: Azathioprine; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Middle Aged; Niacin; Pellagra | 2011 |
Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases.
Topics: Adult; Aged; Antirheumatic Agents; Azathioprine; Dermatomyositis; Diabetes Complications; Female; Fo | 2011 |
Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine.
Topics: Administration, Intravenous; Administration, Oral; Adrenal Cortex Hormones; Adult; Azathioprine; Coh | 2012 |
Anti-signal recognition particle-positive juvenile polymyositis successfully treated with rituximab.
Topics: Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Azathioprine; Child; Drug Therapy, Combinati | 2012 |
Polymyositis masquerading as motor neuron disease.
Topics: Adrenal Cortex Hormones; Aged; Azathioprine; Biopsy; Cervical Vertebrae; Deglutition Disorders; Diag | 2003 |
[Can we predict the risk of malignancy associated with dermatomyositis?].
Topics: Adenocarcinoma; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprin | 2003 |
A method for extracting muscle information from serum creatine kinase measurements--its potential value in the monitoring and management of inflammatory muscle disease.
Topics: Animals; Azathioprine; Clinical Enzyme Tests; Creatine Kinase; Drug Interactions; Humans; Indoles; I | 2006 |
Rituximab as therapy for refractory polymyositis and dermatomyositis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD19; Azathioprine; B-Lymp | 2006 |
Anti-Jo-1 antibody positive polymyositis--successful therapy with leflunomide.
Topics: Antibodies, Antinuclear; Arthritis; Autoantibodies; Azathioprine; Drug Therapy, Combination; Female; | 2006 |
[Anti-signal recognition particle (SRP) antibody positive polymyositis refractory to corticosteroid treatment].
Topics: Adult; Antibodies, Antinuclear; Azathioprine; Biomarkers; Drug Therapy, Combination; Female; Humans; | 2007 |
What is your neurologic diagnosis? Immune-mediated or infectious polymyositis.
Topics: Animals; Azathioprine; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Neurologic Examination | 1995 |
Therapy-related acute myeloid leukaemia following immunosuppression with azathioprine for polymyositis.
Topics: Acute Disease; Azathioprine; Chromosome Deletion; Chromosomes, Human, Pair 5; Chromosomes, Human, Pa | 1994 |
[Pharyngeal dysphagia and polymyositis].
Topics: Aged; Azathioprine; Deglutition Disorders; Enteral Nutrition; Female; Humans; Pharyngeal Diseases; P | 1993 |
Limitations of randomized clinical trials to recognize possible advantages of combination therapies in rheumatic diseases.
Topics: Arthritis, Rheumatoid; Auranofin; Azathioprine; Drug Combinations; Humans; Lupus Erythematosus, Syst | 1993 |
Bronchiolitis obliterans organizing pneumonia in polymyositis. A case report with longterm survival.
Topics: Adult; Azathioprine; Bronchi; Bronchiolitis Obliterans; Female; Humans; Lung; Pneumonia; Polymyositi | 1993 |
Cyclosporine treatment for dermatomyositis/polymyositis.
Topics: Azathioprine; Cyclosporine; Dermatomyositis; Female; Humans; Hydroxychloroquine; Middle Aged; Polymy | 1993 |
Inclusion body myositis: clinical and pathological boundaries.
Topics: Aged; Azathioprine; Biopsy; Creatine Kinase; Dermatomyositis; Diagnosis, Differential; Female; Human | 1996 |
Polymyositis, alopecia universalis, and primary sclerosing cholangitis in a patient with Crohn's disease.
Topics: Adult; Alopecia; Anti-Inflammatory Agents; Antigens, CD; Azathioprine; Cholangiopancreatography, End | 1996 |
Skeletal muscle studies in patients with HIV-related wasting syndrome.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Biopsy; Female; HIV Wasting Syndrome; Humans; Immunos | 1997 |
[Myositis in the presence of slightly elevated creatine kinase values].
Topics: Adult; Azathioprine; Biopsy; Creatine Kinase; Diagnosis, Differential; Humans; Male; Middle Aged; Mu | 1999 |
Pulse intravenous cyclophosphamide treatment for steroid-resistant interstitial pneumonitis associated with polymyositis.
Topics: Adult; Azathioprine; Biopsy; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosupp | 1999 |